SLC1A5 and cancer: Mutations in ASCT1 have been associated with neurodevelopmental deficits, such as alterations in motor function, spatial learning, and affective behavior [35], while expression levels of ASCT2 have been reported to be increased in several cancers, including brain, colon, pancreas, liver, and lung cancer [36,37].